Key findings: Prescribing trends Using a subset of real-world electronic health record (EHR) data from Truveta, Truveta Research identified people who were prescribed a GLP-1 RA between January 01, 2018 and December 31, 2024
The finish is initially a touch dewy but will dry down matte
Santa Cruz Biotechnology, Santa Cruz, CA) and an anti-mCherry rat antibody (#M11217, 1:1000
Regular monitoring and follow-up: Regular monitoring of weight, blood sugar levels, and potential side effects is essential throughout Semaglutide treatment
This unique metabolism profile allows semaglutide to maintain a long half-life, supporting once-weekly injectable dosing
Mikdachi and Dunsmoor-Su 2025 in Current Opinion in Obstetrics and Gynecology concluded GLP-1 receptor agonists are consistently the most effective pharmacologic for weight loss in peri and postmenopausal women, while flagging that dedicated randomized trials do not yet exist